Radiation-related cancer risk associated with surveillance imaging for metastasis from choroidal melanoma

Archives of Ophthalmology

Volumn 131, Issue 1, 2013, Pages 56-61

  Wen, Joanne C ^a   Sai, Victor ^b   Straatsma, Bradley R ^a   McCannel, Tara A ^a  

^a JULES STEIN EYE INSTITUTE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; ARTICLE; ATTRIBUTABLE RISK; CANCER EPIDEMIOLOGY; CANCER RISK; CHOROID MELANOMA; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DISTANT METASTASIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RADIATION DOSE; RADIATION INDUCED NEOPLASM; RADIOACTIVITY; WHOLE BODY CT; WHOLE BODY PET; BODY BURDEN; CHOROID TUMOR; COMPUTER ASSISTED TOMOGRAPHY; EPIDEMIOLOGICAL MONITORING; LIVER TUMOR; MELANOMA; METASTASIS; METHODOLOGY; MIDDLE AGED; MONTE CARLO METHOD; PATHOLOGY; RADIOMETRY; RISK ASSESSMENT; RISK FACTOR; SCINTISCANNING; WHOLE BODY IMAGING; WHOLE BODY RADIATION; ABDOMINAL RADIOGRAPHY; CANCER DIAGNOSIS; CILIARY BODY TUMOR; CONTROLLED STUDY; IONIZING RADIATION; PELVIS RADIOGRAPHY; RADIATION CARCINOGENESIS; THORAX RADIOGRAPHY;

ADULT; AGED; BODY BURDEN; CHOROID NEOPLASMS; EPIDEMIOLOGICAL MONITORING; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LIVER NEOPLASMS; MALE; MELANOMA; MIDDLE AGED; MONTE CARLO METHOD; NEOPLASMS, RADIATION-INDUCED; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; RADIATION DOSAGE; RADIOMETRY; RADIOPHARMACEUTICALS; RISK ASSESSMENT; RISK FACTORS; TOMOGRAPHY, X-RAY COMPUTED; WHOLE BODY IMAGING; WHOLE-BODY IRRADIATION; YOUNG ADULT;

MLCS; MLOWN;

EID: 84872322509     PISSN: 00039950     EISSN: 15383601     Source Type: Journal    
DOI: 10.1001/jamaophthalmol.2013.564     Document Type: Article

References (33)

1. Mooy CM, De Jong PT. Prognostic parameters in uveal melanoma: a review. Surv Ophthalmol. 1996;41(3):215-228. (Pubitemid 26424326)
2. Diener-West M, Reynolds SM, Agugliaro DJ, et al Collaborative Ocular Melanoma Study Group. Development of metastatic disease after enrollment in the COMS trials for treatment of choroidal melanoma: Collaborative Ocular Melanoma Study Group Report No. 26. Arch Ophthalmol. 2005;123(12):1639-1643. (Pubitemid 41785095)
3. Collaborative Ocular Melanoma Study Group. Assessment of metastatic disease status at death in 435 patients with large choroidal melanoma in the Collaborative Ocular Melanoma Study (COMS): COMS report no. 15. Arch Ophthalmol. 2001;119(5):670-676.
4. Augsburger JJ, Corrêa ZM, Shaikh AH. Effectiveness of treatments for metastatic uveal melanoma. Am J Ophthalmol. 2009;148(1):119-127.
5. Hicks C, Foss AJ, Hungerford JL. Predictive power of screening tests for metastasis in uveal melanoma. Eye (Lond). 1998;12(pt 6):945-948. (Pubitemid 29027034)
6. Diener-West M, Reynolds SM, Agugliaro DJ, et al; Collaborative Ocular Melanoma Study Group Report 23. Screening for metastasis from choroidal melanoma: the Collaborative Ocular Melanoma Study Group Report 23. J Clin Oncol. 2004;22(12):2438-2444. (Pubitemid 41115402)
7. Eskelin S, Pyrhönen S, Summanen P, Prause JU, Kivelä T. Screening for metastatic malignant melanoma of the uvea revisited. Cancer. 1999;85(5):1151-1159. (Pubitemid 29115596)
8. Finger PT, Kurli M, Reddy S, Tena LB, Pavlick AC. Whole body PET/CT for initial staging of choroidal melanoma. Br J Ophthalmol. 2005;89(10):1270-1274. (Pubitemid 41638863)
9. Kurli M, Reddy S, Tena LB, Pavlick AC, Finger PT. Whole body positron emission tomography/computed tomography staging of metastatic choroidal melanoma. Am J Ophthalmol. 2005;140(2):193-199.
10. Freton A, Chin KJ, Raut R, Tena LB, Kivelä T, Finger PT. Initial PET/CT staging for choroidal melanoma: AJCC correlation and second nonocular primaries in 333 patients. Eur J Ophthalmol. 2012;22(2):236-243.
11. Xing Y, Cromwell KD, Cormier JN. Review of diagnostic imaging modalities for the surveillance of melanoma patients. Dermatol Res Pract. 2012;2012:941921.
12. Hall EJ, Brenner DJ. Cancer risks from diagnostic radiology. Br J Radiol. 2008;81(965):362-378. (Pubitemid 351743850)
13. Committee to Assess Health Risks from Exposure to Low Level of Ionizing Radiation; National Research Council. Health Risks From Exposure to Low Levels of Ionizing Radiation: BEIR VII - Phase 2. Washington, DC: National Academies Press; 2006.
14. United Nations Scientific Committee on the Effects of Atomic Radiation. Sources and Effects of Ionizing Radiation: United Nations Committee on the Effects of Atomic Radiation: UNSCEAR 1993 Report to the General Assembly, With Scientific Annexes. New York, NY: United Nations; 1993.
15. Einstein AJ, Henzlova MJ, Rajagopalan S. Estimating risk of cancer associated with radiation exposure from 64-slice computed tomography coronary angiography. JAMA. 2007;298(3):317-323. (Pubitemid 47080486)
16. O'Connor MK, Li H, Rhodes DJ, Hruska CB, Clancy CB, Vetter RJ. Comparison of radiation exposure and associated radiation-induced cancer risks from mammography and molecular imaging of the breast. Med Phys. 2010;37(12):6187- 6198.
17. Huppmann MV, Johnson WB, Javitt MC. Radiation risks from exposure to chest computed tomography. Semin Ultrasound CT MR. 2010;31(1):14-28.
18. Tarin TV, Sonn G, Shinghal R. Estimating the risk of cancer associated with imaging related radiation during surveillance for stage I testicular cancer using computerized tomography. J Urol. 2009;181(2):627-632; discussion 632-633.
19. Brenner DJ, Elliston CD. Estimated radiation risks potentially associated with full-body CT screening. Radiology. 2004;232(3):735-738. (Pubitemid 39100257)
20. Huang B, Law MW, Khong PL. Whole-body PET/CT scanning: estimation of radiation dose and cancer risk. Radiology. 2009;251(1):166-174.
21. Jones DG, Shrimpton PC. NRPB-SR250: normalised organ doses for x-ray computed tomography calculated using Monte Carlo techniques. Health Protection Agencywebsite. http://www.hpa.org.uk/Publications/Radiation/NPRBArchive/ NRPBSoftware/. Published 1993. Accessed October 4, 2012.
22. ICRP. Radiation dose to patients from radiopharmaceuticals: addendum 3 to ICRP Publication 53: ICRP Publication 106: approved by the commission in October 2007. Ann ICRP. 2008;38(1-2):1-197.
23. ICRP. 1990 Recommendations of the International Commission on Radiological Protection. Ann ICRP. 1991;21(1-3):1-201.
24. Ivanov VK, Kashcheev VV, Chekin SY, et al. Radiation-epidemiological studies of thyroid cancer incidence in Russia after the Chernobyl accident (estimation of radiation risks, 1991-2008 follow-up period). Radiat Prot Dosimetry. 2012;151(3):489-499.
25. Land CE, Tokunaga M, Koyama K, et al. Incidence of female breast cancer among atomic bomb survivors, Hiroshima and Nagasaki, 1950-1990. Radiat Res. 2003;160(6):707-717. (Pubitemid 37521714)
26. Brix G, Lechel U, Glatting G, et al. Radiation exposure of patients undergoing whole-body dual-modality 18F-FDG PET/CT examinations. J Nucl Med. 2005;46(4):608-613. (Pubitemid 41716405)
27. Damato B, Eleuteri A, Taktak AF, Coupland SE. Estimating prognosis for survival after treatment of choroidal melanoma. Prog Retin Eye Res. 2011;30(5):285-295.
28. Shields CL, Kaliki S, Furuta M, Mashayekhi A, Shields JA. Clinical spectrum and prognosis of uveal melanoma based on age at presentation in 8,033 cases. Retina. 2012;32(7):1363-1372.
29. Francken AB, Fulham MJ, Millward MJ, Thompson JF. Detection of metastatic disease in patients with uveal melanoma using positron emission tomography. Eur J Surg Oncol. 2006;32(7):780-784. (Pubitemid 44276011)
30. Strobel K, Bode B, Dummer R, et al. Limited value of 18F-FDG PET/CT and S-100B tumour marker in the detection of liver metastases from uveal melanoma compared to liver metastases from cutaneous melanoma. Eur J Nucl Med Mol Imaging. 2009;36(11):1774-1782.
31. Orcurto V, Denys A, Voelter V, et al. (18)F-fluorodeoxyglucose positron emission tomography/computed tomography and magnetic resonance imaging in patients with liver metastases from uveal melanoma: results from a pilot study. Melanoma Res. 2012;22(1):63-69.
32. Antoch G, Vogt FM, Freudenberg LS, et al. Whole-body dual-modality PET/CT and whole-body MRI for tumor staging in oncology. JAMA . 2003;290(24):3199- 3206. (Pubitemid 38020681)
33. Augsburger JJ, Corrêa ZM, Trichopoulos N. Surveillance testing for metastasis from primary uveal melanoma and effect on patient survival. Am J Ophthalmol. 2011;152(1):5.e1-9.e1.